DENTSPLY SIRONA Holds Annual Stockholder Meeting

An update from DENTSPLY SIRONA ( (XRAY) ) is now available.

On May 21, 2025, DENTSPLY SIRONA held its annual meeting of stockholders where several key decisions were made. These included the election of eleven directors, the ratification of Deloitte and Touche LLP as the company’s independent accountants for 2025, approval of executive compensation for 2024, and an amendment to increase shares under the 2024 Omnibus Incentive Plan. These decisions reflect the company’s ongoing governance and strategic planning efforts.

The most recent analyst rating on (XRAY) stock is a Hold with a $30.00 price target. To see the full list of analyst forecasts on DENTSPLY SIRONA stock, see the XRAY Stock Forecast page.

Spark’s Take on XRAY Stock

According to Spark, TipRanks’ AI Analyst, XRAY is a Neutral.

DENTSPLY SIRONA’s stock is challenged by declining revenue and profitability, high leverage, and operational difficulties, as highlighted in the financial performance. Despite some technical momentum and a high dividend yield, the valuation remains unattractive due to negative earnings. The earnings call underscores operational efficiency but acknowledges significant challenges ahead, contributing to a cautious outlook.

To see Spark’s full report on XRAY stock, click here.

More about DENTSPLY SIRONA

DENTSPLY SIRONA Inc. operates in the dental industry, providing dental products and technologies, including dental equipment and consumables. The company focuses on innovation and quality in the dental market.

Average Trading Volume: 3,377,512

Technical Sentiment Signal: Sell

Current Market Cap: $3.33B

Find detailed analytics on XRAY stock on TipRanks’ Stock Analysis page.